Abbott landed an emergency use authorization (EUA) for a new at-home coronavirus antigen test where users can perform the test on themselves via digital guidance and get results in 20 minutes. The test, priced at $25, is prescription based.
This isn't the first EUA for the testing product, known as BinaxNOW. However, the tool's first authorization designated that medical personnel conduct the...
